COMMUNIQUÉS West-GlobeNewswire

Intuitive Announces Fourth Quarter Earnings
23/01/2025
SUNNYVALE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial [...]
Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich’s Ataxia
23/01/2025
Adolescents receive a weight-based dose equivalent to the 50 mg adult dose Adolescents 12-17 years old who complete participation in the pharmacokinetic (PK) run-in study will be eligible to screen in the ongoing open [...]
Grant of Restricted Stock Units and Warrants to Employees in Genmab
23/01/2025
Company Announcement COPENHAGEN, Denmark; January 23, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 4,903 restricted stock units and 5,289 warrants to employees of the Company and the [...]
Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3
23/01/2025
NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI
23/01/2025
NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant natural killer T (iNKT) [...]
Vessl Prosthetics Secures Oversubscribed Pre-Seed Funding to Drive Innovation in Prosthetic Solutions
23/01/2025
LONDON, Ontario, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Vessl, a London-based startup specializing in advanced prosthetic systems, is proud to announce the successful completion of its first funding round, securing [...]
America’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search
23/01/2025
The Regeneron Science Talent Search Celebrates and Rewards Today’s Most Talented Young Minds Driving Innovation and Progress through Scientific Exploration TARRYTOWN, N.Y. and WASHINGTON, D.C., Jan. 23, 2025 (GLOBE [...]
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
23/01/2025
HOUSTON, TX, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar today, January 23, 2025, at 4:15 p.m. ET. The [...]
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
23/01/2025
Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announced Medicare Price Assignment ROSELAND, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading [...]
Medisensonic S.A. Modern medical technologies with growing investment potential
23/01/2025
WARSAW, Poland, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Medisensonic S.A., a Polish MedTech joint-stock company with an estimated market value of more than €15 million, is one of the very promising players in the market. The [...]
Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer
23/01/2025
Industry changemaker to drive transformation and operational improvements in the development and delivery of the company’s healthcare products, solutions, and services MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- [...]
LAPIX Therapeutics Doses First Patient-In Phase 1b Clinical Trial of LPX-TI641 for Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)
23/01/2025
LPX-TI641 is a novel, orally bioavailable, potent small-molecule immunomodulator that restores immune tolerance by targeting multiple pathways implicated in autoimmune diseases. Topline Phase 1 clinical data for LPX- [...]
DLH to Announce Fiscal 2025 First Quarter Financial Results
23/01/2025
ATLANTA, Jan. 23, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital [...]
Outlook Therapeutics® Announces Presentation of Efficacy and Safety Results from NORSE EIGHT Clinical Trial Evaluating ONS-5010 for the Treatment of Wet AMD
23/01/2025
Data presented at Hawaiian Eye and Retina 2025 Meeting Results confirmed that intravitreal ONS-5010 provided early and sustained anatomic improvements, with steady gains in BCVA and reliable, consistent safety ONS-5010 [...]
PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider
23/01/2025
MENLO PARK, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Global Institute for Food Security (GIFS) at [...]
Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic
23/01/2025
- Up to 200 subjects will receive four curated strains never before given in combination as a synbiotic treatment, as part of a development plan to improve infant health outcomes - SAN DIEGO, Jan. 23, 2025 (GLOBE [...]
PathAI Partners with Discovery Life Sciences to Deploy First AI-Powered Biospecimen Solutions
23/01/2025
Collaboration Marks First At-Scale Deployment of AI Technologies into Leading Commercial Biobank BOSTON and HUNTSVILLE, Ala, Jan. 23, 2025 (GLOBE NEWSWIRE) -- PathAI, a leading provider of AI-powered technology for [...]
Tiziana Life Sciences not to engage in capital raising activities for the immediate future
23/01/2025
NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
AIM ImmunoTech Announces Publication of Final Clinical Study Results for AMP-518 Clinical Trial on Ampligen as a Therapeutic for Post-COVID Conditions
23/01/2025
OCALA, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and Safety [...]

Pages